Skip to main content
Clinical Trials/IRCT201410303186N6
IRCT201410303186N6CompletedPhase 3

The Assessment of Achillea millefolium ointment therapeutic effects on idiopathic recurrent epistaxis: A Randomized double blind clinical trial study

Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Inclusion critria: the patients who referred to the clinic of Besat hospital with recurrent epistaxis (minimum of 3 times per 2 months) and no specific etiology detect on history and physical exam
  • Exclusion criteria:
  • 1- Age under 12 and above 50 years old.
  • 2- Pregnancy.
  • 3- OCP use.
  • 4- Hx of ischemic heart disease.
  • 5- Hx of hypertension.
  • 6- Hx of thromboamboli.
  • 7- Hx of allergy to Achillia
  • 8- Coagulation disorder.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences

Similar Trials